VAQTA 25 [iU]/.5mL
hepatitis A vaccine, inactivated · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
VAQTA is a injection, suspension containing hepatitis a vaccine, inactivated at 25 [iU]/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- VAQTA
- Generic Name
- hepatitis A vaccine, inactivated
- NDC Code (Product)
0006-4831- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 25 [iU]/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103606
- Marketing Start
- 03/29/1996
Recall History
No Recall HistoryFrequently Asked Questions
What is VAQTA used for?
VAQTA contains hepatitis A vaccine, inactivated. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is VAQTA a controlled substance?
VAQTA is not classified as a controlled substance by the DEA.
What is the generic name for VAQTA?
The generic name for VAQTA is hepatitis A vaccine, inactivated. There are no other listed brand versions of hepatitis A vaccine, inactivated.
What is the NDC code for VAQTA 25 [iU]/.5mL?
The NDC (National Drug Code) for VAQTA 25 [iU]/.5mL is 0006-4831, listed by Merck Sharp & Dohme LLC.
Other VAQTA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)